Clinical Trials Logo
  1. Home
  2. Cerebral Hemorrhage
  3. NCT02935985

Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers — EsICH  

Cerebral Hemorrhage Clinical Trial

Official title:
Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers

Clinical Trial Summary

The bio-markers substudy of EsICH is designed to recruit patients with acute (first 8h) spontaneous intracerebral hemorrhage and assess a series of biological parameters (CBC, glucose, cholesterol, LDL cholesterol, triglycerides) and point-of-care bio-markers (cTnI, hsCRP, D-Dimer) in order to predict the functional outcome of these patients and to determine their input for early risk stratification and prognosis.

Clinical Trial Description

EsICH is designed as a multicenter double blind randomized (2:1) clinical trial assessing the effects of tranexamic acid (2g in total) on patients with acute (first 8h) spontaneous intracerebral hemorrhage.

The bio-markers substudy addresses the same category of patients and assesses biological parameters (CBC, glucose, cholesterol, LDL cholesterol, triglycerides) and point-of-care bio-markers (cTnI, hsCRP, D-Dimer) in order to predict the functional outcome of these patients and to determine their input for early risk stratification and prognosis.

The patients with a diagnostic CT scan are recruited in the Emergency Departments or Neurology/ Neurosurgery Wards of the hospitals enrolled in the study and blood samples are drawn in the first 8h from the onset of the condition. The patient is then clinically assessed by the study investigators for the first 7 days of the admission and a second CT scan is performed on the second day (24h from the onset of the condition).

Telephone follow-ups will be completed on day 90 and 180 by the coordinating center of the study.

The bio-markers substudy is an observational, prospective multicenter (the study will be initially started in one center - Cluj-Napoca - and then the Tirgu Mures center will be activated. Two more centers might be also included on a later time - Alba and Bistrita-Nasaud, pending on financial and logistic reasons). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02935985
Study type Observational
Source Iuliu Hatieganu University of Medicine and Pharmacy
Contact
Status Completed
Phase
Start date December 12, 2016
Completion date November 24, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT04741334 - Mild Head Injury, Antiplatelets, and Anticoagulants
Completed NCT02565693 - Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation Phase 2
Recruiting NCT01866384 - Targeted Temperature Management After Intracerebral Hemorrhage Phase 2
Completed NCT00029315 - Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage Phase 2
Active, not recruiting NCT06230419 - Retrospective Study on the Direction of Artificial Intelligence in Identifying Cranial Trauma CT Imaging
Not yet recruiting NCT04144868 - Safety and Efficacy of NBO in Acute Intracerebral Hemorrhage N/A
Recruiting NCT05118997 - Active Removal of IntraCerebral Hematoma Via Active Irrigation N/A
Active, not recruiting NCT02258919 - Decompressive Hemicraniectomy in Intracerebral Hemorrhage N/A
Completed NCT01472224 - Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial Ultrasound N/A
Recruiting NCT06078020 - PLatform Study for INTracerebral Haemorrhage (PLINTH): Community-based Feasibility Study
Completed NCT01467206 - Life After STroke - the LAST Study N/A
Completed NCT00226096 - Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage N/A
Recruiting NCT03815149 - Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
Completed NCT00579943 - Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants N/A
Recruiting NCT05424614 - Study on the Prognostic Prediction Model of Patients With Acute Intracerebral Hemorrhage by Artificial Intelligence
Completed NCT03000283 - Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study Phase 1
Active, not recruiting NCT02283879 - Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela Phase 1
Active, not recruiting NCT02240394 - TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure N/A
Completed NCT01858675 - Biomarkers Correlation With Volemia N/A
Completed NCT00363662 - Diagnostic Utility of MRI in Intracerebral Hemorrhage